EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Huntington's disease clinical trials update: October 2025

Mena Farag iD, Sarah J Tabrizi, Edward J Wild

Journal of Huntington's Disease · 2026-02 · 15 (1) · 156-166

DOI: 10.1177/18796397251399751 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Huntington's Disease, online erschienen am 26.11.2025. Verfasst von Mena Farag und 2 weiteren Autor:innen. Beteiligte Einrichtung: Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: Huntington Disease, Clinical Trials as Topic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this edition of the Huntington's Disease Clinical Trials Update, we expand on the launch of the phase II/III clinical trial of SKY-0515 from Skyhawk Therapeutics and the phase I/II clinical trial of SPK-10001 from Spark Therapeutics. We also report positive topline data from uniQure's phase I/II clinical trial of AMT-130 after 36 months of follow-up. Further updates include recent developments in Roche's tominersen programme within GENERATION HD2, progress with votoplam (PTC518) in PIVOT-HD by PTC Therapeutics and developments in the collaborative PTC Therapeutics/Novartis programme. We additionally discuss regulatory developments regarding pridopidine following the negative PROOF-HD study. Finally, we provide an updated listing of all registered and ongoing clinical trials in Huntington's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseClinical Trials as TopicHumans

Stichwörter der Autor:innen

Huntington's diseaseclinical trials

Autor:innen und Institutionen

  • Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.

ORCID-Profile: Mena Farag

Förderung

  • Wellcome Trust

Zitieren

APA

Farag, M., Tabrizi, S. J., & Wild, E. J. (2026). Huntington's disease clinical trials update: October 2025. Journal of Huntington's Disease, 15(1), 156-166. https://doi.org/10.1177/18796397251399751

Vancouver

Farag M, Tabrizi SJ, Wild EJ. Huntington's disease clinical trials update: October 2025. Journal of Huntington's Disease. 2026;15(1):156-166. doi:10.1177/18796397251399751

BibTeX
@article{Farag2026,
  author = {Farag, Mena and Tabrizi, Sarah J and Wild, Edward J},
  title = {Huntington's disease clinical trials update: October 2025},
  journal = {Journal of Huntington's Disease},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {156--166},
  doi = {10.1177/18796397251399751}
}
Kostenlos starten →